Skip to content

Myriad Genetics MYGN Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

NeoGenomics logo
NeoGenomicsNEO
Veracyte logo
VeracyteVCYT
Natera, Inc. logo
Natera, Inc.NTRA
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
Mesa Laboratories logo
Mesa LaboratoriesMLAB
Castle Biosciences logo
Castle BiosciencesCSTL

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
Enterprise value$598.35M+17.3%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's accrued manufacturing costs?
Myriad Genetics (MYGN) reported accrued manufacturing costs of $39.8M in Q1 2026.
How has Myriad Genetics's accrued manufacturing costs changed year-over-year?
Myriad Genetics's accrued manufacturing costs decreased by 7.4% year-over-year, from $43M to $39.8M.
What is the long-term trend for Myriad Genetics's accrued manufacturing costs?
Over 5 years (2020 to 2025), Myriad Genetics's accrued manufacturing costs has grown at a 0.9% compound annual growth rate (CAGR), from $48.9M to $51.2M.